LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 93.92 | 21.74 | 1122 | 6070 | 0.1848 | 0.6248 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 93.92 | 21.74 | 6836 | 6070 | 1.1262 | 1.0295 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 2.24 | 21.74 | 549 | 183 | 2.9907 | 1.8550 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 2.24 | 21.74 | 480 | 183 | 2.6148 | 1.7331 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 4.24 | 21.74 | 731 | 317 | 2.3003 | 1.4804 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 4.24 | 21.74 | 780 | 317 | 2.4545 | 1.5223 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 6.21 | 21.74 | 836 | 392 | 2.1327 | 1.3981 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 6.21 | 21.74 | 888 | 392 | 2.2653 | 1.4330 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 8.19 | 21.74 | 1 | 439 | 0.0023 | -0.5082 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 8.19 | 21.74 | 894 | 439 | 2.0325 | 1.3552 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 8.19 | 21.74 | 1 | 439 | 0.0023 | -0.5082 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 8.19 | 21.74 | 961 | 439 | 2.1848 | 1.3947 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 10.16 | 21.74 | 2 | 463 | 0.0043 | -0.4175 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 10.16 | 21.74 | 909 | 463 | 1.9606 | 1.3295 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 10.16 | 21.74 | 1 | 463 | 0.0022 | -0.5022 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 10.16 | 21.74 | 985 | 463 | 2.1245 | 1.3722 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 12.13 | 21.74 | 2 | 496 | 0.0040 | -0.4106 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 12.13 | 21.74 | 922 | 496 | 1.8575 | 1.2941 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 12.13 | 21.74 | 1 | 496 | 0.0020 | -0.4945 | MN20160310_N01 | L15 |